CSF and plasma GABA levels in Parkinson's disease
AUTOR(ES)
Abbott, RJ
RESUMO
CSF gamma-aminobutyric acid (GABA) levels were reduced in patients with idiopathic Parkinson's disease when compared with age matched controls, but the difference was not significant. However, when the Parkinsonian patients were subdivided, CSF GABA levels were lower in the levodopa treated group than in the untreated group and the controls. There was no difference in plasma GABA levels between Parkinsonian patients and controls.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=491347Documentos Relacionados
- CSF somatostatin-like immunoreactivity in dementia of Parkinson's disease.
- Gamma vinyl GABA in the treatment of levodopa-induced dyskinesias in Parkinson's disease.
- Interleukin-6 serum levels in patients with Parkinson's disease
- Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease
- Plasma Urate and Parkinson's Disease in the Atherosclerosis Risk in Communities (ARIC) Study